Zymewire is a well-established, revenue-generating B2B SaaS company ($8M+ annual revenue) providing sales intelligence to the biotech/pharma industry. While the project itself demonstrates high real-world utility and verified traction far exceeding the calibration baseline, the submission quality was exceptionally poor, containing false claims (e.g., 'most people have used my product', 'audience: everyone') and invalid data fields. The score reflects the strong underlying business fundamentals, heavily penalized by the lack of accurate self-reporting.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline